User profiles for Joseph J Eron
 | Joseph J EronProfessor of Medicine, University of North Carolina at Chapel Hill Verified email at med.unc.edu Cited by 73977 |
[HTML][HTML] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic …
…, LM Demeter, JS Currier, JJ Eron Jr… - … England Journal of …, 1997 - Mass Medical Soc
Background The efficacy and safety of adding a protease inhibitor to two nucleoside
analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We …
analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We …
[HTML][HTML] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
Background The new protease inhibitors are potent inhibitors of the human immunodeficiency
virus (HIV), and in combination with other antiretroviral drugs they may be able to cause …
virus (HIV), and in combination with other antiretroviral drugs they may be able to cause …
[HTML][HTML] Effect of early versus deferred antiretroviral therapy for HIV on survival
Background The optimal time for the initiation of antiretroviral therapy for asymptomatic patients
with human immunodeficiency virus (HIV) infection is uncertain. Methods We conducted …
with human immunodeficiency virus (HIV) infection is uncertain. Methods We conducted …
[HTML][HTML] Cabotegravir for HIV prevention in cisgender men and transgender women
Background Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP)
for human immunodeficiency virus (HIV) infection are needed to increase the options …
for human immunodeficiency virus (HIV) infection are needed to increase the options …
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society–USA panel
SM Hammer, JJ Eron, P Reiss, RT Schooley… - Jama, 2008 - jamanetwork.com
Context The availability of new antiretroviral drugs and formulations, including drugs in new
classes, and recent data on treatment choices for antiretroviral-naive and -experienced …
classes, and recent data on treatment choices for antiretroviral-naive and -experienced …
[HTML][HTML] Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
…, DR Kuritzkes, JJ Eron Jr, J Chung… - … England Journal of …, 2003 - Mass Medical Soc
Background The T-20 vs. Optimized Regimen Only Study 1 (TORO 1) was a randomized,
open-label, phase 3 study of enfuvirtide (T-20), a human immunodeficiency virus type 1 (HIV-1) …
open-label, phase 3 study of enfuvirtide (T-20), a human immunodeficiency virus type 1 (HIV-1) …
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel
Context New trial data and drug regimens that have become available in the last 2 years
warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency …
warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency …
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1
…, D Zimba, PL Vernazza, M Maida, SA Fiscus, JJ Eron - The Lancet, 1997 - thelancet.com
Background Transmission of HIV-1 is predominantly by heterosexual contact in sub-Saharan
Africa, where sexually transmitted diseases (STDs) are also common. Epidemiological …
Africa, where sexually transmitted diseases (STDs) are also common. Epidemiological …
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
There is an urgent need for an effective, oral, direct-acting therapeutic to block transmission
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent progression …
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent progression …
Brief but efficient: acute HIV infection and the sexual transmission of HIV
CD Pilcher, HC Tien, JJ Eron… - Journal of infectious …, 2004 - academic.oup.com
Background . We examined whether viral dynamics in the genital tract during the natural
history of acute human immunodeficiency virus type 1 (HIV-1) infection could explain efficient …
history of acute human immunodeficiency virus type 1 (HIV-1) infection could explain efficient …